DRPevader: Ex vivo-diagnosis and prognosis of early diabetic retinopathy
A novel ex vivo method for immediate early diagnosis and prognosis of proliferative diabetic retinopathy (DRP) is provided with DRPevader.
DRPevader is based on the analysis of expression and activity of very few genes which can simply be determined using whole blood or a blood component. Therefore, DRPevader is the diagnostic link between the alteration of leukocyte gene expression, the activity of specific serum-markers, and proliferative DRP.
Further Information: PDF
PROvendis GmbH
Phone: +49 (0)208/94105 0
Contact
Dipl.-Ing. Alfred Schillert
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Attosecond core-level spectroscopy reveals real-time molecular dynamics
Chemical reactions are complex mechanisms. Many different dynamical processes are involved, affecting both the electrons and the nucleus of the present atoms. Very often the strongly coupled electron and nuclear…
Columbia researchers “unzip” 2D materials with lasers
The new technique can modify the nanostructure of bulk and 2D crystals without a cleanroom or expensive etching equipment. In a new paper published on May 1 in the journal…
Decoding development: mRNA’s role in embryo formation
A new study at Hebrew University reveals insights into mRNA regulation during embryonic development. The study combines single-cell RNA-Seq and metabolic labeling in zebrafish embryos, distinguishing between newly-transcribed and pre-existing…
